Emerson Chen

Emerson Chen

Oregon Health & Science University - Portland / United States
Medical and Health Sciences / Health Sciences
AD Scientific Index ID: 885784
person_outline Emerson Chen's MOST POPULAR ARTICLES
1-) Estimation of the percentage of US patients with cancer who benefit from genome-driven oncologyJ Marquart, EY Chen, V PrasadJAMA oncology 4 (8), 1093-1098, 20182762018
2-) An overview of cancer drugs approved by the US Food and Drug Administration based on the surrogate end point of response rateEY Chen, V Raghunathan, V PrasadJAMA internal medicine 179 (7), 915-921, 2019972019
3-) Estimation of study time reduction using surrogate end points rather than overall survival in oncology clinical trialsEY Chen, SK Joshi, A Tran, V PrasadJAMA internal medicine 179 (5), 642-647, 2019702019
4-) Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b studyJJ Harding, J Fan, DY Oh, HJ Choi, JW Kim, HM Chang, L Bao, HC Sun, ...The Lancet Oncology 24 (7), 772-782, 20231092023
5-) FDA acceptance of surrogate end points for cancer drug approval: 1992-2019EY Chen, A Haslam, V PrasadJAMA internal medicine 180 (6), 912-914, 2020902020